Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

POLARx Post Approval Study (POLARx PAS)

NCT: NCT06170606 · COMPLETED

NCT IDNCT06170606
StatusCOMPLETED
Start Date2024-06-28
Completion2026-05-20
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

To collect clinical data on safety, effectiveness and procedural success of Boston Scientific's Cardiac Cryoablation System (includes all BSC commercially available POLARx/POLARx Fit catheters) when used to perform pulmonary vein isolation (PVI) in the ablation treatment of de novo Atrial Fibrillation (AF).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑